Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
BMC Cancer|December 29, 2022
Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs designD Doppenberg, M G Besselink, C H J van Eijck, et al.
Trials|October 29, 2022
A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE)I W J M van Goor, L A Daamen, M G Besselink, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 17, 2024
Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer: An international expert survey and case vignette studyN C Biesma, M U J E Graus, G A Cirkel, et al.
Trials|September 24, 2022
Prophylactic abdominal drainage or no drainage after distal pancreatectomy (PANDORINA): a binational multicenter randomized controlled trialF L Vissers, A Balduzzi, E A van Bodegraven, et al.
Gut|August 27, 2015
Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancerJ A M G Tol, J E van Hooft, R Timmer, et al.
International Journal of Surgery (London, England)|January 24, 2024
Implementation and outcome of minimally invasive pancreatoduodenectomy in Europe: a registry-based retrospective study - a critical appraisal of the first 3 years of the E-MIPS registryAnouk M L H Emmen, Nine de Graaf, I E Khatkov, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 14, 2020
The treatment and survival of elderly patients with locally advanced pancreatic cancer: A post-hoc analysis of a multicenter registryL J H Brada, M S Walma, R M van Dam, et al.
Annals of Surgical Oncology|June 27, 2024
Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide StudyI W J M van Goor, P C M Andel, F S Buijs, et al.
Trials|June 20, 2024
Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts designL A Daamen, I W J M van Goor, V P Groot, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2026
The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analysisJ C M Scheepens, K J Prinsze, L G van Geest, et al.
Pageof 5